chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Significant burning with admin of first shot. Approx 3.5 hours after shot I could not move my arm at the shoulder.  This was more than muscle soreness but being unfamiliar with Covid vaccine, I just rode it out. This lasted 2 days.  Since then, my shoulder joint has not been the same with sl limited ROM and persistent pain.   This improved signif over the 3 weeks until my 2nd Covid vaccine 1/7/21.  This is what tipped me off that the first shot was not correct.  #2 did not burn at all with administration or cause any limited ROM.  Typical deltoid soreness sl more than a tetanus shot, and general "flu like sxs" that lasted < 24 hours.
2NOV95 pt recv vax & exp discomfort;2 noc p/vax pt fell asleep w/inj arm over head & awoke next morning w/arm pain & dec mobility of the arm & shoulder;dx w/frozen shoulder tx w/physical therapy;
SORE THROAT WITHOUT REDNESS OR WHITE PATCHES; SORE LEFT ARM WITHOUT REDNESS AND SWELLING; ARM FELT HEAVY; This spontaneous report received from a patient concerned a 68 year old female. The patient's weight was 145 pounds, and height was 66 inches. The patient's concurrent conditions included: hypothyroidism, hypertension, sleep apnea, latex allergy, non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient was not pregnant at the time of vaccination, no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820096, expiry: 21-OCT-2021) dose was not reported, administered on 11-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-AUG-2021, the patient experienced sore left arm without redness and swelling. On 11-AUG-2021, the patient experienced arm felt heavy. Laboratory data included: Pain scale (NR: not provided) 9/10. On 12-AUG-2021, the patient experienced sore throat without redness or white patches. Laboratory data included: Pain scale (NR: not provided) 2-3/10, 4/10. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from sore left arm without redness and swelling, had not recovered from sore throat without redness or white patches, and the outcome of arm felt heavy was not reported. This report was non-serious.
Fatigue after second dose of Moderna vaccine- sleeping 12 hour or more at one time , soreness that has improved
6-22-07 mom called to report redness and SW at injection site, denied fever, hives, difficulty breathing. R thigh. 6/25/07 Mom brought pt in fever 101-102 and sore throat days 4&5 after vaccines. Temp 98 this morning. R lat thigh has approx 7cm area of red/purple discoloration, mildly swollen and mildly warm.
2:30pm shot given, 2:42pm started to hyperventilate, pt layed on ground with feet elevated, pt did not fall, 140/90mmhg 147bpm 99% o2 sat, 2:50pm 10%oxygen given, 2:56pm 140/90mmhg, 2:59 hyperventilation stopped, 3:04pm 100bpm 150/100mmhg 99% o2 sat, 3:15pm 112/90mmhg 100bpm 98% o2 sat and 108mg/dl blood sugar. pt went to ambulance and er 3:20pm pt is slow to respond and is not fully aware.
This spontaneous report was received from a Registered Nurse regarding her son of of approximately 20 months of age. No medical history or drug allergies were reported. On an unknown date in April 2009, the patient was vaccinated with a dose of VARIVAX (Merck) (lot #, expiry not reported), 0.5 ml, subcutaneously. No concomitant medications were reported. On an unknown date in 2010, the patient developed bright red blistered rash. The nurse reported that the rash was localized to her son's left leg starting from his left upper thigh down to his knee. Patient sought medical attention (patient was seen by physician on an unspecified date). The patient was treated with acyclovir on an unspecified date. Laboratory diagnostics studies performed was none. The nurse also reports that the rash took a couple of weeks to resolve. Additional information is not expected.
Pentacel was ordered but not administered, Menveo vaccine was given in error. Patient waited 20 minutes after vaccine and No reacrion was noted at this time.
Approx 10 min after receiving vaccine, pt fell forwards but father caught. 911 was called pupils dilated but returned to normal quickly. Family of 5 was in room at time of vaccine. Per EMS - vitals normal and parents will take child to ED.
A report has been received from a Health Professional concerning a female patient. No information was provided regarding the concomitant medications, concurrent diseases and medical history of the patient. The patient number eight received the FLUMIST vaccine (intranasal), 0.2 ml, dose, one time intranasally, for the prevention of the flu, date of vaccination not provided. It was unknown if the dose of 0.1 ml was given in each nostril. The office refrigerator had a temperature excursion of 1.5 degrees C for a total of 17.5 hours. The temperature would be at recommended temperature range and then dip to 1.5 degrees C, then go back to original range. FLUMSIT was continued. The outcome of the events of patient given FLUMIST vaccine after a temperature excursion of 1.5 c for 17.5 hours/temperature excursion of FLUMIST vaccine given to 14 patients and it is unknown if the dose of 0.1 ml was given in each nostril/patient number one received FLUMIST vaccine 0.2ml dose, one time intranasally was unknown. The report was considered to be non-serious by company physician.
flue like symptoms; No appetite; bed ridden for a whole day; Achy body; nauseous; Fever of 100.3; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flue like symptoms), DECREASED APPETITE (No appetite), BEDRIDDEN (bed ridden for a whole day), MYALGIA (Achy body) and NAUSEA (nauseous) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol and Acid reflux (esophageal). Concomitant products included FAMOTIDINE for Acid reflux (esophageal), ROSUVASTATIN for Cholesterol, METOPROLOL for an unknown indication.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (flue like symptoms), DECREASED APPETITE (No appetite), BEDRIDDEN (bed ridden for a whole day), MYALGIA (Achy body), NAUSEA (nauseous) and PYREXIA (Fever of 100.3). On 05-Nov-2021, PYREXIA (Fever of 100.3) had resolved. On 06-Nov-2021, BEDRIDDEN (bed ridden for a whole day) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flue like symptoms), DECREASED APPETITE (No appetite), MYALGIA (Achy body) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Nov-2021, Body temperature: 100.3 (High) Body temperature High-100.3.         Reporter stated that patient was taking concomitant medication metoprolol for betablocker, rosuvastatin for cholesterol control and famotidine for acid reflux. Treatment details was not reported by the reporter.
Extreme tremors making use of hands in any and all tasks handling dishes, using microwave, kitchen utensils, providing personal hygiene and everything one does throughout the day involving hands.
antibody test/ no antibodies were in her blood; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on Oct2020 at a single dose as Covid vaccine. Medical history and concomitant medications were not reported. The patient had a question regarding production of antibodies after receiving Covid vaccine. The received the vaccine last October, had antibody test late October2020 and in January2021, and no antibodies were in her blood. The patient inquired, "Does that mean the shot was not effective and should I get another shot?" The outcome of the event was unknown.  Information on Lot/Batch number has been requested.
Patient received second Pfizer shot on Saturday, then on Sunday night, she had some heavy breathing. Her sinuses started acting up, too. She has no energy and wants to sleep all the time. Oxygen at home running 96-97 percent. Feels a heaviness in her chest which she thinks is due to asthma. She does not have a current inhaler. No wheezing and feels like she has to cough. She has some bloody nasal discharge when she blows her nose. Is using sinus rinses every morning and there is little mucus coming out. "
Bell?s palsy. Facial paralysis on the right side of my face. Still ongoing.
Pt developed pain on the left arm/shoulder on the following day, followed by nausea, dizziness, profound weakness, hot/cold seats; no fever no chills, no SOB, no cough.
pt recvd vax 16DEC94 in the afternoon; mom says pt cried & screamed nearly continually thereafter sleeping for less than an hr @ a time until went to sleep 0200AM 18DEC & was found @ 0400 dead in bed; slept 2 hrs p/vax then started crying;
27JUL96 family member noted knot (quarter size) in RLT;no soreness or redness told to apply warm packs & see MD if knot inc in size or gets warm to touch or red;
Injection side was warm; Injection side was itchy; "Large red big circle" in injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection side was warm), VACCINATION SITE PRURITUS (Injection side was itchy) and VACCINATION SITE ERYTHEMA ("Large red big circle" in injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection side was warm), VACCINATION SITE PRURITUS (Injection side was itchy) and VACCINATION SITE ERYTHEMA ("Large red big circle" in injection site). The patient was treated with CORTISONE for Vaccination site pruritus, Vaccination site erythema and Vaccination site warmth, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (Injection side was warm), VACCINATION SITE PRURITUS (Injection side was itchy) and VACCINATION SITE ERYTHEMA ("Large red big circle" in injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  The patient used cortisone cream as treatment, but the symptoms still did not go away.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with a dose of VARIVAX lot # N019822, expiration date 13-JUL-2019 (dose and route of administration were not reported) for prophylaxis. The vaccine was reconstituted with improperly stored sterile diluent (manufacturer unknown) (lot # and expiration date were not provided). No adverse events were reported. The sterile diluent had been improperly stored at a temperature of -1 degree Celsius or colder (-10 degrees Celsius) for 6 days, through unknown number of cycles. There had been no previous temperature excursion. Digital Data Logger was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1711USA003734:
1st dose 2 years ago, never received second.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received a dose of Shingrix 2 years ago.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: Age at vaccination was not applicable for this report. The patient received a dose of Shingrix 2 years before the reporting and did not receive second dose. Till the time of reporting, the patient did not receive 2nd dose of vaccine, which led to incomplete course of vaccination. Consent to follow up was granted.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021012475:Same reporter
Fever; This is a spontaneous report from a non-contactable consumer. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Jun2021 as a single dose for COVID-19 immunisation. It was reported that medical history of the patient was not available. The patient has taken unspecified concomitant medications. The patient's history of known allergies was reported as none. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on May2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Jun2021, the day after the vaccine the patient experienced fever. It was unknown whether any therapeutic measures were taken as a result of this event. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event fever was recovered on an unknown date in Jun2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a health professional concerning a greater than 12 week old patient who, on an unknown date, was vaccinated with an oral dose of ROTATEQ. No adverse experience was related to this event. No other information has been provided. Additional information is not expected.
pt recv 4th dose of vax 15OCT93 & lab eval on 9NOV93 revealed anti-HBS less than 2.1; On 31MAY94 a repeat Epstein-Barr VCA IgG was 1:40 & CMV IgG was greater than 6.4; CMV culture on 9JUN94 was neg; No further details were provided;
A physician reported ganglion cyst in a 34 year old female after receiving her first dose of Flumist. The patient received Flumist at 3 PM on the afternoon of 10/29/04. The patient noticed lumps on her right wrist that resembled a ganglion cyst the afternoon of 10/31/04. More of the cyst-like symptoms developed around her wrist 11/1/04. By 11/2/04, the cyst had spread to both wrist, feet, and ankles. On 11/3/04, the cyst were spreading to her arms. The reporter stated that it maybe urticaria but he is not quite sure how to identify the events. He is referring the patient to another physician. As of 11/5/04, the cyst have not progressed but have not resolved. The reporter stated he did not believe the event were due to use of Flumist. 07Feb05: Additional information obtained: pt's age and date of birth.
chills; difficult to sleep; headache; pain+soreness in my left arm (injection site); pain+soreness in my left arm (injection site); This is a spontaneous report from a non-contactable consumer (herself). A 26-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EL3247, Expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 at 09:30 (Age at vaccination 26-years-old) as dose 2, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EL3247, Expiry date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jan2021 09:15 as dose 1, single for covid-19 immunisation. On 19Feb2021 11:30, the patient experienced about 2 hours after 2nd dose of vaccine, noticed a headache that was gradually increasing and pain + soreness in my left arm (injection site) became apparent. No treatment was taken, the side effects are manageable without medications. About 18-20 hours after my 2nd vaccine dose (20Feb2021), noticed headaches that lasted through the night which made it difficult to sleep, in addition to chills. This lasted about 6-8 hours and then had subsided. Also, I woke up with pain at the injection site and muscle soreness but has since gotten better. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the events. The clinical outcome of the events was recovered on an unspecified date 2021.  No follow-up attempts are possible. No further Information is expected.
Gave the first dose of Moderna Vaccine to a patient 17.5 years old , not officially 18 and over
I felt a little off, like I had a small, slight cold; My arm was sore; Slight cold; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (I felt a little off, like I had a small, slight cold), PAIN IN EXTREMITY (My arm was sore) and NASOPHARYNGITIS (Slight cold) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 013A21A) for COVID-19 vaccination.     The patient's past medical history included Heart failure, Tachycardia, Bradycardia, Atrial fibrillation, Atrial flutter, Dressler's syndrome ((Pericarditis)), COVID-19 (Patient tested positive), Hip replacement (Left hip done 7 months ago.), Thoracotomy (Took blood out of patient lungs. Patient had a thoracotomy to correct problem.) and Surgery (About 8 or 9 yrs ago patient had Mini-Maze heart surgery.). Concurrent medical conditions included COPD. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced MALAISE (I felt a little off, like I had a small, slight cold), PAIN IN EXTREMITY (My arm was sore) and NASOPHARYNGITIS (Slight cold). The patient was treated with ALBUTEROL [SALBUTAMOL] ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and AMOXICILLIN for Adverse event, at a dose of 875 mg twice a day. At the time of the report, MALAISE (I felt a little off, like I had a small, slight cold), PAIN IN EXTREMITY (My arm was sore) and NASOPHARYNGITIS (Slight cold) outcome was unknown.            This case was linked to MOD-2021-404300, MOD-2021-404411 (Patient Link).
For the first two-three weeks I had a feeling that something was not right with my veins on the back of my knees e.g. could not sit for more than a few minutes and had to "walk it off". Once those symptoms were gone I was left with  a discomfort or pain in my veins  especially when my arms, wrists and my knees are bent and there is no normal flow. The pain is similar to as if you accidentally crashed your vein or if you were a few days hooked up to an IV from the same spot. If feels like a low grade vein inflammation that just does not go away. My veins are in general sensitive to pressure now.  I nevere had such symptoms until I took Janssen. I saw the vascular specialist and they ruled out blood cloths or varicose veins problems. Over all blood tests look OK. Yet  I am left with this pain and no one knows what this is about. Is this some kind of auto-immune response?.
This spontaneous report as received from a registered pharmacist refers to a 66 years old female patient with sulfa drugs allergy. The patient was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 IM into the right deltoid (Lot # not reported) on 10-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. On approximately 10-OCT-2012, "sometime on 10-OCT-2012 or early on 11-OCT-2012", the patient experienced swelling and heat at the injection site and pain in the lower extremity, fever of 100 F, some anxiety, and it was hard to sleep. The pharmacist stated that the patient called her doctor who asked why she got another dose of PNEUMOVAX 23 since she already had a dose in January 2012, so the patient had 2 doses of PNEUMOVAX 23 within 9 months time. No treatment was given for the events although the pharmacist stated comfort measure of compress was recommended. The reporter stated that the patient was feeling a little bit better on 11-OCT-2012. The relationship of the events with PNEUMOVAX 23 was not reported. Additional information has been requested.
Narrative:  Influenza vaccine was administered in left deltoid. Patient developed rash and hives involving right arm and back. Patient denied any new medications or OTC products.
Rash to back, abdomen.  subjective symptoms: fever, ache, chills
drooping of the left side of her face/Bell's Palsy; very high BP; A spontaneous report was received from a consumer concerning an approximately 44-years-old female patient who received Moderna's  Covid 19 vaccine (mRNA1273) and who developed Bell's Palsy (facial paralysis) and high blood pressure (BP) (hypertension).  The patient's medical history was not provided. Concomitant product use was not provided/unknown by the reporter.    The patient received first of two planned dose of mRNA-1273 intramuscularly on 19-JAN-2021 for prophylaxis of Covid 19 infection.  On 22-FEB-2021 patients had a high BP of 130/80 mmHg. Patient noticed drooping of the left side of face. The patient went to the emergency room, was found to have very high BP, and was diagnosed with Bell's Palsy and was getting a CT scan. Treatment for the event included Prednisone.  Action taken with mRNA-1273 in response to the events was not provided/unknown.  The outcome of the event were considered unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Severe severe headache that won't quit. Headache goes all the way down my neck. Chills, fever, dizziness, nausea.
pt recv vax APR98 & 1 day post vax pt devel a non-pruritic rash w/white bumps on both arms & legs;fatigue;also exp itching sensation;